Related Experiment Video
Updated: Jan 21, 2026

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
Published on: September 13, 2014
Acute hepatitis B notification rates in Flanders, Belgium, 2009 to 2017
Özgür Koc1,2,3, Pierre Van Damme4, Dana Busschots1,2
1Department of Gastroenterology and Hepatology, Ziekenhuis Oost-Limburg, Genk, Belgium.
Insights
Hepatitis B notification rates significantly decreased in Flanders due to prevention strategies. However, enhanced measures are crucial for adult risk groups, especially men who have sex with men, to further control hepatitis B transmission.
Area of Science:
- Public Health
- Infectious Disease Epidemiology
- Vaccinology
Background:
- Belgium implemented universal infant hepatitis B vaccination and a catch-up program for 10-13 year olds in 1999.
- The study focuses on Flanders, a region with historically low hepatitis B endemicity.
Purpose of the Study:
- To assess the impact of hepatitis B prevention and control strategies on acute hepatitis B notification rates.
- To analyze trends in hepatitis B notification rates across different age groups and demographic populations in Flanders from 2009 to 2017.
Main Methods:
- An observational study utilizing mandatory hepatitis B notifications to the Agency for Care and Health in Flanders.
- Collection of demographic data and identification of risk factors associated with acute hepatitis B cases.
- Analysis of notification rates per 100,000 population over the study period (2009-2017).
Main Results:
- Acute hepatitis B notification rates in Flanders declined from 1.6 to 0.7 per 100,000 population between 2009 and 2017.
- Significant decreases were observed across all age groups, including a notable drop in young children (0-4 years).
- Sexual activity was the primary transmission route (30.7%), with an increasing trend in men who have sex with men (MSM) post-2014; five cases of mother-to-child transmission were reported.
Conclusions:
- Current hepatitis B prevention and control strategies have been effective in lowering overall notification rates in Flanders.
- There is an ongoing need for intensified prevention and control measures targeting specific adult risk groups, particularly MSM, to address persistent transmission routes.
Abstract:
BackgroundBelgium is a low-endemic country for hepatitis B. Universal hepatitis B vaccination in infants with catch-up in the age cohort of 10-13 year-olds began in 1999.AimsOur objective was to evaluate the effect of prevention and control strategies on acute hepatitis B notification rates in Flanders (Belgium) from 2009 to 2017.MethodsThis observational study collected demographic data and risk factors for acute hepatitis B from mandatory notifications to the Agency for Care and Health.ResultsIn Flanders, acute hepatitis B notification rates per 100,000 population decreased from 1.6 in 2009 to 0.7 in 2017. These rates declined in all age groups: 0-4-year-olds: 0.6 to 0.0, 5-14-year-olds: 0.2 to 0.0, 15-24-year-olds: 0.8 to 0.7, 25-34-year-olds: 3.4 to 1.1 and ≥ 35-year-olds: 1.59 to 0.7. There was also a downward trend in acute hepatitis B notification rates in native Belgians and first-generation migrants. Among 15-24-year-olds and 25-34-year-olds, a possible reversal of the decreasing trend was observed in 2016 and 2015, respectively. Among 548 acute hepatitis B cases, the main route of transmission was sexual activity (30.7%), and the pattern of transmission routes over time showed an increasing proportion of sexual transmission in men who have sex with men (MSM) after 2014. During the period from 2009 to 2017, five mother-to-child transmissions were reported.ConclusionsPrevention and control strategies were effective in reducing the acute hepatitis B notification rate. However, stronger prevention and control measures are needed in adult risk groups, particularly MSM.
Related Concept Videos
Reaction Rate
The mathematical representation of the change in the concentration of reactants and products, over time, is the rate...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Speciation Rates
Related Rates
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

